Patents Assigned to AdipoGenix, Inc.
  • Publication number: 20050233403
    Abstract: The invention features methods of obtaining high-yield, essentially pure human predipocyte cultures. Cultures obtained according to the instant methodology are also featured as are methods of identifying adipogenic modulatory agents, e.g., high-throughput screening assays.
    Type: Application
    Filed: May 1, 2003
    Publication date: October 20, 2005
    Applicant: AdipoGenix, Inc.
    Inventors: Michael Stevenson, James Kirkland
  • Publication number: 20050014194
    Abstract: Methods of identifying insulin response modulators are provided. Therapeutic methods utilizing compounds identified according to the methods of the invention are also provided. In particular, methods of treating diabetes and insulin resistance are provided.
    Type: Application
    Filed: July 25, 2003
    Publication date: January 20, 2005
    Applicant: AdipoGenix, Inc.
    Inventor: Cydney Brooks
  • Publication number: 20040248836
    Abstract: Methods for treating diabetes and/or insulin resistance by administering an activator of FHOS are disclosed.
    Type: Application
    Filed: July 25, 2003
    Publication date: December 9, 2004
    Applicant: AdipoGenix, INC.
    Inventor: Cydney C. Brooks
  • Publication number: 20030144350
    Abstract: The present invention pertains to compounds effective at modulating fatty acid or triglyceride (“fat”) accumulation by cells, such compounds having therapeutic potential as regulators of body mass and for the treatment of overweight individuals, obesity, and metabolic disorders. Featured compounds are set forth and exemplified herein. Therapeutic methods and pharmaceutical compositions featuring these compounds are also provided.
    Type: Application
    Filed: July 22, 2002
    Publication date: July 31, 2003
    Applicant: AdipoGenix, Inc.
    Inventors: Michael John Stevenson, Harrison Jefferson Leighton
  • Publication number: 20030130343
    Abstract: The present invention pertains to compounds effective at modulating fatty acid or triglyceride accumulation by fat cells, such compounds having therapeutic potential as regulators of body mass and for the treatment of overweight individuals, obesity, and metabolic disorders.
    Type: Application
    Filed: August 8, 2002
    Publication date: July 10, 2003
    Applicant: AdipoGenix, Inc.
    Inventors: Michael John Stevenson, Harry Jefferson Leighton